(Q44482792)

3 December 2017

title

Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease (English)

1 reference

3 December 2017

T F Jonasson

1

1 reference

3 December 2017

T Hedner

series ordinal

2

1 reference

3 December 2017

B Hultberg

series ordinal

3

1 reference

3 December 2017

H Ohlin

series ordinal

4

1 reference

3 December 2017

publication date

1 July 2003

1 reference

European Journal of Clinical Investigation

3 December 2017

published in

1 reference

3 December 2017

volume

33

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

543-549

1 reference

Total homocysteine and cardiovascular disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

The effects of oral methionine and homocysteine on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Influence of Folic Acid on Postprandial Endothelial Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

Folic acid fortification of the food supply. Potential benefits and risks for the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01184.X

10.1046/J.1365-2362.2003.01184.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference